News & Perspective

Nov 15, 2011

Nov 15, 2011

Study finds urban centers can serve as flu virus sources

(CIDRAP News) – New seasonal flu viruses can launch from one of many world urban centers, not just from tropical areas in Southeast and East Asia, as previously thought, a research group reported yesterday.

May 20, 2011

May 20, 2011

Flu situation stays sedate, locally and globally

(CIDRAP News) – Flu indicators fell again in the United States last week as the 2010-11 flu season approaches its end, with very little activity occurring elsewhere in the world, US and global surveillance organizations said today.

All levels were below baseline, even the percentage of deaths from pneumonia and flu, which has lagged the decline of other flu signals, the US Centers for Disease Control and Prevention (CDC) said today.

Jan 18, 2011

Jan 18, 2011

Northern Hemisphere countries show steady rise in flu

(CIDRAP News) – Flu activity is increasing in many of the Northern Hemisphere's temperate-zone countries, with influenza B cocirculating with the 2009 pandemic H1N1 virus across Europe and teaming up with influenza A (H3N2) in the United States and Canada, the World Health Organization (WHO) said in its latest update.

Sep 10, 2010

Sep 10, 2010

Japan approves second new flu antiviral this year

(CIDRAP News) – Japan today approved a new long-acting influenza antiviral drug, Inavir (laninamivir), made by Daiichi Sankyo Co. Ltd., marking the second new flu drug licensed there this year.

Aug 28, 2009

Aug 28, 2009

WHO cites severe H1N1 cases as southern outbreaks wane

(CIDRAP News) – Novel H1N1 influenza outbreaks are starting to wane in the southern hemisphere, and while most cases are still mild, clinicians are reporting some severe cases of viral pneumonia in young, previously healthy people, the World Health Organization (WHO) said today.

Pages

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»